Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 24 of 79

  1. A deep understanding of potential molecular biomarkers and therapeutic targets related to the progression of colorectal cancer (CRC) from early stages to metastasis remain mostly undone. Moreover, the regulati...

    Authors: Pouria Samadi, Meysam Soleimani, Fatemeh Nouri, Fatemeh Rahbarizadeh, Rezvan Najafi and Akram Jalali
    Citation: BMC Cancer 2022 22:835
    Content type: Research Published on:

  2. Hypoxic tumors are known to be highly resistant to radiotherapy and cause poor prognosis in non-small cell lung cancer (NSCLC) patients. CKD-516, a novel vascular disrupting agent (VDA), mainly affects blood v...

    Authors: Min-Young Kim, Jung-Young Shin, Jeong-Oh Kim, Kyoung-Hwa Son, Yeon Sil Kim, Chan Kwon Jung and Jin-Hyoung Kang
    Citation: BMC Cancer 2020 20:1057
    Content type: Research article Published on:

  3. Ovarian cancer is a heterogeneous disease and prognosis for apparently similar cases of ovarian cancer varies. Recurrence of the disease in early stage (FIGO-stages I-II) serous ovarian cancer results in survi...

    Authors: Ingiridur Skirnisdottir, Markus Mayrhofer, Maria Rydåker, Helena Åkerud and Anders Isaksson
    Citation: BMC Cancer 2012 12:407
    Content type: Research article Published on:

  6. Researches have manifested that the disorder of iron metabolism is participated in Gastric cancer (GC), but whether iron metabolism-relevant genes (IMRGs) is related to the survival outcome of GC remain unknown.

    Authors: Xihong Liu, Junyu Ren, Ruize Zhou, Zhengqi Wen, Zhengwei Wen, Zihao Chen, Shanshan He and Hongbin Zhang
    Citation: BMC Cancer 2023 23:1106
    Content type: Research Published on:

  7. Platinum compounds are the mainstay of chemotherapy for lung cancer. Unfortunately treatment failure remains a critical issue since about 60 % of all non-small cell lung cancer (NSCLC) patients display intrins...

    Authors: Hogir Salim, Dali Zong, Petra Hååg, Metka Novak, Birgitta Mörk, Rolf Lewensohn, Lovisa Lundholm and Kristina Viktorsson
    Citation: BMC Cancer 2015 15:628
    Content type: Research article Published on:

  8. This study was to determine the prevalence and clinical significance of clonal hematopoiesis (CH)-related variants, and somatic and germline mutations in cancer patients and healthy individuals.

    Authors: Chieh-Min Chang, Kuei-Ching Lin, Nien-En Hsiao, Wei-An Hong, Chia-Yu Lin, Ta-Chih Liu, Ya-Sian Chang and Jan-Gowth Chang
    Citation: BMC Cancer 2022 22:413
    Content type: Research Published on:

  9. Metastatic disease is a major and difficult-to-treat complication of lung cancer. Considering insufficient effectiveness of existing therapies and taking into account the current problem of lung cancer chemore...

    Authors: E. Skurikhin, N. Ermakova, M. Zhukova, E. Pan, D. Widera, L. Sandrikina, L. Kogai, O. Pershina, A. Pakhomova, V. Yu. Pan, N. Kushlinskii, A. Kubatiev, S. Morozov and A. Dygai
    Citation: BMC Cancer 2024 24:522
    Content type: Research Published on:

  10. Although isolated central nervous system (CNS) relapses are rare, they may become a serious clinical problem in intensively treated patients with high-risk neuroblastoma (NBL). The aim of this study is the pre...

    Authors: Aleksandra Wieczorek, Joanna Stefanowicz, Marcin Hennig, Elzbieta Adamkiewicz-Drozynska, Marzena Stypinska, Bozenna Dembowska-Baginska, Zuzanna Gamrot, Mariola Woszczyk, Julia Geisler, Tomasz Szczepanski, Szymon Skoczen, Marek Ussowicz, Monika Pogorzala, Szymon Janczar and Walentyna Balwierz
    Citation: BMC Cancer 2022 22:701
    Content type: Research Published on:

  11. Pneumonitis is a possible side effect of radiotherapy for lung cancer. Since it can occur up to several months following treatment, symptoms may not be associated with previous radiotherapy, and pneumonitis ca...

    Authors: Dirk Rades, Elisa Marie Werner, Esther Glatzel, Marie-Christine Eggert, Denise Olbrich, Soeren Tvilsted and Sabine Bohnet
    Citation: BMC Cancer 2020 20:785
    Content type: Study protocol Published on:

  12. Leptin (LEP) has been consistently associated with angiogenesis and tumor growth. Leptin exerts its physiological action through its specific receptor (LEPR). We have investigated whether genetic variations in LE...

    Authors: Kaouther Snoussi, A Donny Strosberg, Noureddine Bouaouina, Slim Ben Ahmed, A Noureddine Helal and Lotfi Chouchane
    Citation: BMC Cancer 2006 6:38
    Content type: Research article Published on:

  13. The postoperative survival effect of the number of examined lymph nodes on patients of R0-resected esophageal squamous cell carcinoma with pathological stage T1–3N0M0 is still unclear.

    Authors: Lei-Lei Wu, Jiu-Di Zhong, Jia-Li Zhu, Lu Kang, Yang-Yu Huang, Peng Lin, Hao Long, Lan-Jun Zhang, Qi-Long Ma, Li-Hong Qiu and Guo-Wei Ma
    Citation: BMC Cancer 2022 22:118
    Content type: Research Published on:

  15. Histone acetyltransferase p300 is a crucial transcriptional coactivator and has been implicated as a poor prognostic factor in human cancers. However, little is known about the substantial functions and mechan...

    Authors: Xue Hou, Run Gong, Jianhua Zhan, Ting Zhou, Yuxiang Ma, Yuanyuan Zhao, Yaxiong Zhang, Gang Chen, Zhonghan Zhang, Shuxiang Ma, Xi Chen, Fangfang Gao, Shaodong Hong, Fan Luo, Wenfeng Fang, Yunpeng Yang…
    Citation: BMC Cancer 2018 18:641
    Content type: Research article Published on:

  16. High-grade salivary gland cancer is a distinct clinical entity that has aggressive disease progression and early systemic spread. However, because of the rarity of the disease, the clinical outcomes, prognosti...

    Authors: Jeon Yeob Jang, Nayeon Choi, Young-Hyeh Ko, Man Ki Chung, Young-Ik Son, Chung-Hwan Baek, Kwan-Hyuck Baek and Han-Sin Jeong
    Citation: BMC Cancer 2018 18:672
    Content type: Research article Published on:

  17. Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the basal-like subtype (with limited discordance) is an aggressive form of the disease which convey unpredictable, and poor prognosis du...

    Authors: Nandini Dey, Benjamin G Barwick, Carlos S Moreno, Maja Ordanic-Kodani, Zhengjia Chen, Gabriella Oprea-Ilies, Weining Tang, Charles Catzavelos, Kimberly F Kerstann, George W Sledge Jr., Mark Abramovitz, Mark Bouzyk, Pradip De and Brian R Leyland-Jones
    Citation: BMC Cancer 2013 13:537
    Content type: Research article Published on:

  18. To demonstrate that post-therapy pathological tumor volume (ypTV) should be considered as an independent prognostic factor in advanced gastric cancer (GC) patients who underwent neoadjuvant chemotherapy (NAC) ...

    Authors: Xiaolong Tang, Qingsi He, Hui Qu, Guorui Sun, Jia Liu, Lei Gao, Jingbo Shi, Jianhong Ye and Yahang Liang
    Citation: BMC Cancer 2019 19:797
    Content type: Research article Published on:

  19. Previous studies have shown that preoperative anemia is correlated with the prognoses of various solid tumors. This study was performed to determine the effect of preoperative anemia on relapse and survival in...

    Authors: YingJun Zhang, YuYang Chen, DongTai Chen, Yu Jiang, Wan Huang, HanDong Ouyang, Wei Xing, MuSheng Zeng, XiaoMing Xie and Weian Zeng
    Citation: BMC Cancer 2014 14:844
    Content type: Research article Published on:

  21. Maintenance treatment (MTx) in responders following first-line treatment has been investigated and practiced for many cancers. Modeling and simulation may support interpretation of interim data and development...

    Authors: Kelong Han, Laurent Claret, Alan Sandler, Asha Das, Jin Jin and Rene Bruno
    Citation: BMC Cancer 2016 16:473
    Content type: Research article Published on:

  22. Lymph node (LN) involvement represents the strongest prognostic factor in colon cancer patients. The objective of this prospective study was to assess the prognostic impact of isolated tumor cells (ITC, define...

    Authors: B. Weixler, R. Warschkow, U. Güller, A. Zettl, U. von Holzen, B. M. Schmied and M. Zuber
    Citation: BMC Cancer 2016 16:106
    Content type: Research article Published on:

  24. Conversion surgery (CS) following a response to chemotherapy occasionally leads to prolonged survival in patients with stage IV gastric cancer (GC). This study aimed to evaluate the predictive value of the neu...

    Authors: Naohiko Nakamura, Shinichi Kinami, Yasuto Tomita, Takashi Miyata, Hideto Fujita, Hiroyuki Takamura, Nobuhiko Ueda and Takeo Kosaka
    Citation: BMC Cancer 2020 20:363
    Content type: Research article Published on:

  25. Triple-negative breast cancer (TNBC) is a highly heterogeneous subtype of breast cancer, showing aggressive clinical behaviors and poor outcomes. It urgently needs new therapeutic strategies to improve the pro...

    Authors: Yiduo Liu, Linxin Teng, Shiyi Fu, Guiyang Wang, Zhengjun Li, Chao Ding, Haodi Wang and Lei Bi
    Citation: BMC Cancer 2021 21:644
    Content type: Research Published on:

  26. Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2...

    Authors: Xiaoli Sheng, Yunxian Li, Yixuan Li, Wenlin Liu, Zhongming Lu, Jiandong Zhan, Mimi Xu, Liangsi Chen, Xiaoning Luo, Gang Cai and Siyi Zhang
    Citation: BMC Cancer 2019 19:840
    Content type: Research article Published on:

  27. The aim of this study was to investigate the optimal order of radiation therapy in patients affected by stage IIIA pathologic N2 (IIIA/N2) non-small-cell lung cancer (NSCLC) and to identify its potential risk ...

    Authors: Hongxia Duan, Long Liang, Shuanshuan Xie and Changhui Wang
    Citation: BMC Cancer 2020 20:809
    Content type: Research article Published on:

  28. Synaptophysin, chromogranin and CD56 are recommended markers to identify pulmonary tumors with neuroendocrine differentiation. Whether the expression of these markers in pulmonary adenocarcinoma and pulmonary ...

    Authors: Katharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, Petros Christopoulos, Michael Thomas, Hauke Winter, Martin Eichhorn, Florian Eichhorn, Moritz von Winterfeld, Esther Herpel, Benjamin Goeppert, Albrecht Stenzinger, Felix J. F. Herth, Arne Warth and Mark Kriegsmann
    Citation: BMC Cancer 2021 21:486
    Content type: Research article Published on:

  29. The identification of circulating tumour cells (CTCs) in peripheral blood is a useful approach to estimate prognosis, monitor disease progression, and measure treatment effects in various malignancies. However...

    Authors: Hiroaki Ito, Haruhiro Inoue, Norimasa Sando, Satoshi Kimura, Keigo Gohda, Jun Sato, Katsuhiro Murakami, Shun Ito, Noriko Odaka, Hitoshi Satodate and Shin-ei Kudo
    Citation: BMC Cancer 2012 12:346
    Content type: Research article Published on:

  30. While molecular targeted drugs and other therapies are being developed for many tumors, pancreatic cancer is still considered to be the malignant tumor with the worst prognosis. We started this study to identi...

    Authors: Shoichiro Tange, Tomomi Hirano, Masashi Idogawa, Eishu Hirata, Issei Imoto and Takashi Tokino
    Citation: BMC Cancer 2023 23:85
    Content type: Research Published on:

  31. To our knowledge, there are no studies to systematically compare the detailed clinical significance between curatively resected pancreatic head (ph) and body-tail (pbt) ductal adenocarcinoma based on the new 8...

    Authors: Weiwei Sheng, Ming Dong, Guosen Wang, Xiaoyang Shi, Wei Gao, Kewei Wang, He Song, Gang Shi and Xiaodong Tan
    Citation: BMC Cancer 2019 19:981
    Content type: Research article Published on:

  33. Hypoxia-inducible factor 1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) are frequently overexpressed in numerous types of cancers and are known to be important regulators of angiogenesis. Until...

    Authors: Dan Cao, Mei Hou, Yong-song Guan, Ming Jiang, Yu Yang and Hong-feng Gou
    Citation: BMC Cancer 2009 9:432
    Content type: Research article Published on:

  35. Overall survival of advanced colorectal cancer (CRC) patients remains poor, and gene expression analysis could potentially complement detection of clinically relevant mutations to personalize CRC treatments.

    Authors: Maxim Sorokin, Marianna Zolotovskaia, Daniil Nikitin, Maria Suntsova, Elena Poddubskaya, Alexander Glusker, Andrew Garazha, Alexey Moisseev, Xinmin Li, Marina Sekacheva, David Naskhletashvili, Alexander Seryakov, Ye Wang and Anton Buzdin
    Citation: BMC Cancer 2022 22:1113
    Content type: Research Published on:

  36. Hepatocellular carcinoma (HCC) genomic research has discovered actionable genetic changes that might guide treatment decisions and clinical trials. Nonetheless, due to a lack of large-scale multicenter clinica...

    Authors: Mengqi Song, Haoyue Cheng, Hao Zou, Kai Ma, Lianfang Lu, Qian Wei, Zejiang Xu, Zirui Tang, Yuanzheng Zhang, Yinan Wang and Chuandong Sun
    Citation: BMC Cancer 2024 24:673
    Content type: Research Published on:

  37. To examine the outcomes and risk factors in pediatric differentiated thyroid carcinoma (DTC) patients who were defined as TNM stage I because some patients develop disease recurrence but treatment strategy for...

    Authors: Nobuyuki Wada, Kiminori Sugino, Takashi Mimura, Mitsuji Nagahama, Wataru Kitagawa, Hiroshi Shibuya, Keiko Ohkuwa, Hirotaka Nakayama, Shohei Hirakawa, Yasushi Rino, Munetaka Masuda and Koichi Ito
    Citation: BMC Cancer 2009 9:306
    Content type: Research article Published on:

  38. Breast cancer is one of the main malignant tumors that threaten the lives of women, which has received more and more clinical attention worldwide. There are increasing evidences showing that the immune micro-e...

    Authors: Lin Chen, Yuxiang Dong, Yitong Pan, Yuhan Zhang, Ping Liu, Junyi Wang, Chen Chen, Jianing Lu, Yun Yu and Rong Deng
    Citation: BMC Cancer 2021 21:329
    Content type: Research article Published on:

  39. Serum miRNA was once found as potential disease survival index,thus we investigated the role of miRNA in predicting prognosis in loco-regionally advanced NPC patients treated with CCRT.

    Authors: Zhimin Zhang, Jiangbiao Huang, Ge Wang, Feng Jin, Jijun Zheng, He Xiao, Lin Lei, Jia Luo and Chuan Chen
    Citation: BMC Cancer 2020 20:183
    Content type: Research article Published on:

  40. Previous studies on cancer of unknown primary (CUP) mainly focus on treatment and prognosis in western populations and lacked clinical evaluation of different IHC markers, so this study aimed to evaluate chara...

    Authors: Min Ren, Xu Cai, Liqing Jia, Qianming Bai, Xiaoli Zhu, Xichun Hu, Qifeng Wang, Zhiguo Luo and Xiaoyan Zhou
    Citation: BMC Cancer 2023 23:1175
    Content type: Research Published on:

  41. The wnt/β-catenin signaling pathway is known to affect in cancer oncogenesis and progression by interacting with the tumor microenvironment. However, the roles of wnt3a and wnt5a in colorectal cancer (CRC) hav...

    Authors: Myung Ah Lee, Jin-Hee Park, Si Young Rhyu, Seong-Taek Oh, Won-Kyoung Kang and Hee-Na Kim
    Citation: BMC Cancer 2014 14:125
    Content type: Research article Published on:

  43. To determine safety and efficacy of radiofrequency ablation (RFA) for local treatment of lung metastases of renal cell carcinoma (RCC), sequenced or combined with systemic treatments.

    Authors: Alexis Gonnet, Laura Salabert, Guilhem Roubaud, Vittorio Catena, Véronique Brouste, Xavier Buy, Marine Gross Goupil, Alain Ravaud and Jean Palussière
    Citation: BMC Cancer 2019 19:1182
    Content type: Research article Published on:

  44. Survivin, an inhibitor of apoptosis is expressed in several human cancers. Its expression is known to be associated with poor clinical outcome, but not widely studied in pancreatic cancer. We performed this st...

    Authors: Myung Ah Lee, Gyeong-sin Park, Hee-Jung Lee, Ji-Han Jung, Jin-Hyoung Kang, Young Seon Hong, Kyung Shik Lee, Dong-gu Kim and Seung-Nam Kim
    Citation: BMC Cancer 2005 5:127
    Content type: Research article Published on:

  45. The Prognostic value of microvessel density in cancer remains unclear. Recent studies have suggested that the uneven distribution of microvessels in tumours caused the variation in sample selection which led t...

    Authors: Jianyi Li, Yang Zhang, Wenhai Zhang, Yang Gao, Shi Jia and Jiao Guo
    Citation: BMC Cancer 2014 14:672
    Content type: Research article Published on:

  46. Genetic testing for BRCA1/2 genes is widely used as a strategy to reduce incidence and morbidity of hereditary breast and ovarian cancer (HBOC). The purpose of this study is to analyse the demographic and molecul...

    Authors: Ainara Ruiz de Sabando, Edurne Urrutia Lafuente, Fermín García-Amigot, Angel Alonso Sánchez, Lourdes Morales Garofalo, Sira Moreno, Eva Ardanaz and Maria A. Ramos-Arroyo
    Citation: BMC Cancer 2019 19:1145
    Content type: Research article Published on:

    The Correction to this article has been published in BMC Cancer 2019 19:1227

  47. Tubulin alpha-1c chain (TUBA1C), a subtype of α-tubulin, has been shown to be involved in cell proliferation and cell cycle progression in several cancers and to influence cancer development and prognosis. How...

    Authors: Xinyao Hu, Hua Zhu, Biao Chen, Xiaoqin He, Yang Shen, Xiaoyu Zhang, Yangtao Xu and Ximing Xu
    Citation: BMC Cancer 2022 22:498
    Content type: Research Published on:

  48. It is unclear whether individualized treatments based on biological factors have improved the prognosis of recurrent breast cancer. The purpose of this study is to evaluate the survival improvement of patients...

    Authors: Hideo Shigematsu, Hidetoshi Kawaguchi, Yoshiaki Nakamura, Kimihiro Tanaka, Satoko Shiotani, Chinami Koga, Sumiko Nishimura, Kenichi Taguchi, Kenichi Nishiyama and Shinji Ohno
    Citation: BMC Cancer 2011 11:118
    Content type: Research article Published on:

  49. To improve the prognosis of patients with metastatic colorectal cancer (mCRC), investigating predictive biomarkers of their prognosis and chemotherapeutic responsiveness is necessary. This study aimed to analy...

    Authors: Kei Furuya, Masao Nakajima, Ryouichi Tsunedomi, Yuki Nakagami, Ming Xu, Hiroto Matsui, Yukio Tokumitsu, Yoshitaro Shindo, Yusaku Watanabe, Shinobu Tomochika, Noriko Maeda, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shoichi Hazama, Tatsuya Ioka…
    Citation: BMC Cancer 2024 24:165
    Content type: Research Published on:

  50. The ErbB family consists of four proteins including (EGFR)/ErbB1, ErbB2, ErbB3, and ErbB4, and plays a crucial role in the promotion of multiple tumorigenic processes. In addition to the traditional pathways o...

    Authors: Keigo Mitsui, Masaoki Yonezawa, Atsushi Tatsuguchi, Seiichi Shinji, Katya Gudis, Shu Tanaka, Shunji Fujimori and Choitsu Sakamoto
    Citation: BMC Cancer 2014 14:863
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us